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Abstract: The plants of genus Cymbopogon are well known for their use in traditional medicine and for their high content 
of essential oils that are widely used as flavoring agents, fragrances, cosmetics, and pharmaceuticals. Essential oils isolated 
from the dried stems and inflorescence of cultivated Cymbopogon schoenanthus (L.) Spreng. (Poaceae) collected from 
Khartoum state (Sudan) in two periods were studied. The results of chemical analysis of C. schoenanthus revealed that this 
plant is rich in essential oil which is a valuable source of the commercially important monoterpene, piperitone (47.7-71.5%). 
Other abundant constituents of the oils were intermedeol (6.1-17.3%), δ-2-carene (4.5-10.0%) and elemol (2.7-9.0%). The 
essential oil from the inflorescence was tested for spasmolytic activity using three different experimental models: against 
spontaneous contractions, contractions induced with acetylcholine and contractions induced with potassium chloride. The 
oil exhibited strong, significant and dose-dependent spasmolytic activity, indicating the possibility for further investigations 
of this essential oil for its medicinal purposes or application in food industry.
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INTRODUCTION 
Essential oils and aromatic plants have been used by 
many cultures around the world for centuries. Their 
uses vary between cultures, from religious to healing 
purposes. Nowadays essential oils have many applica-
tions in medicine, pharmacy, cosmetics and the food 
industry. Interest in aromatic plants and essential oils 
has increased substantially in the last decades due to 
their high medicinal and economic value [1].
Cymbopogon Spreng. (Poaceae) is a genus of about 
180 species, subspecies, varieties, and subvarieties that 
inhabit warm and tropical regions of the Old World 
and Oceania [2]. Species of this genus are well known 
for their use in traditional medicine as well as for their 
remarkably high content of essential oils with pleasant 
aroma and wide usage for flavoring, fragrances, cos-
metics, pharmaceuticals and perfumery [3]. Addition-
ally, the oils possess numerous biological activities, in-
cluding antimicrobial, anticancer, pesticidal, mosquito 
repellent, antiinflammatory and hypoglycemic activity 
[4]. The best-known species of this genus in terms of 
commercially important essential oils are: C. citratus 
Stapf (East Indian lemongrass) and C. flexuosus Stapf 
(West Indian lemongrass) that produce lemongrass 
oil, C. martini Stapf (palmarosa oil source), C. nar-
dus (L.) Rendle and C. winterianus Jowitt, which give 
citronella oil [5].
Cymbopogon schoenanthus (L.) Spreng. (camel 
grass) is an aromatic herb, common in northern Af-
rica [6]. This plant is used as a culinary herb in salads 
and traditional meat dishes. Because of its pleasant 
aroma, it is also consumed as a refreshing beverage 
prepared by steeping the aerial parts in hot water [7]. 
Its medicinal properties were considered helpful in 
the treatment of gout, prostate inflammation, kidney 
disorders, stomach pain, fever and rheumatism [6,8]. 
Furthermore, C. schoenanthus is traditionally used as 
a digestive, for treating intestinal spasms as well as 
for treating anorexia, i.e. for increasing appetite [7,9]. 
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Previous studies examining biological activities 
showed that C. schoenanthus oil exhibits insecticidal 
[10,11], antitrypanosomal [8], antioxidant and ace-
tylcholinesterase activities [9]. In addition, C. citratus 
Stapf and C. martinii Stapf., which are traditionally 
used as antispasmodics, were previously investigated 
to validate their use in folk medicine. The results have 
shown that extracts of these plants exhibit strong and 
significant spasmolytic activity in vitro [12,13].
Bearing in mind the abovementioned uses of C. 
schoenanthus, our aim was to investigate the spas-
molytic activity of its inflorescence oil to contribute 
to the evaluation of the traditional use of this plant. 
Moreover, a comprehensive analysis of the essential 
oils from the stems and inflorescence of cultivated C. 
schoenanthus collected in two different periods was 
carried out in order to assess variability in the chemi-
cal composition of the essential oil.
MATERIALS AND METHODS
Chemicals
Alverine (alverine citrate salt), atropine (atropine 
sulfate salt monohydrate), potassium chloride (KCl), 
1,1-diphenyl 2-picryl-hydrazyl (DPPH) and acetyl-
choline (ACh, acetylcholine iodide) were obtained 
from Sigma Chemical Corp. (USA).
Plant material and essential oil isolation 
The aerial parts of C. schoenanthus were collected 
from the experimental field of the Medicinal & Aro-
matic Plants Research Institute (MAPRI), Khartoum, 
Sudan, in November 2013 and in February 2015 
(Table 1). The voucher specimens are deposited at 
MAPRI, Khartoum, Sudan. The essential oils were 
isolated from the air-dried and powdered stems and 
inflorescences by hydrodistillation for 2 h, using a 
Clevenger-type apparatus. 
GC and GC-MS analyses
GC and GC-MS analyses were carried out using an 
Agilent 6890N Gas Chromatograph equipped with a 
split/splitless injector (200°C), a HP-5MS capillary 
column (30 m x 0.25 mm; film thickness 0.25 μm) 
and flame ionization detector (FID), and coupled 
with an Agilent 5975 MS Detector (MSD) operating 
in the electron impact (EI) mode at 70 eV. The FID 
and transfer line temperatures were set at 300°C and 
250°C, respectively. The carrier gas was He (1.0 mL/
min), and the oven temperature was programmed 
from 60 to 280°C at a rate of 3°C/min. The injected 
volume was 1 μl and the split ratio 10:1.
Identification of the compounds was based on 
a comparison of their retention indices (KI), reten-
tion times (RT) and mass spectra with those from 
the NIST/NBS, Wiley libraries and the literature [14]. 
The linear KIs were determined in relation to a homo-
logues series of n-alkanes (C8-C40) run under the 
same operating conditions [15]. Relative percentages 
of compounds were calculated based on the peak areas 
from the FID data.
Spasmolytic activity
The essential oil from inflorescence of C. schoenanthus 
collected in February 2015 (sample CI-2) was tested 
for spasmolytic activity.
Isolation of ratileum
Six- to eight-week-old Wistar rats (160-200 g) of both 
sexes were used in this study. All experimental proce-
dures with animals where conducted in compliance 
with Directive 2010/63/EU of the European Parliament 
and of the Council of Europe from 22 September 2010 
and approved by Ethical Committee of the University 
of Niš – Faculty of Medicine. Rats were killed by cervi-
cal dislocation and exsanguination. The ileum portions 
were isolated out, the mesenteries were removed and 
2-cm-long preparations were mounted in 10-mL tissue 
baths containing Tyrode’s solution (NaCl 136.9; KCl 
2.68; CaCl2 1.8; MgCl2 1.05; NaHCO3 11.9; NaH2PO4 
0.42 and glucose 5.55 mM), maintained at 37ºC and 
aerated with a mixture of 5% carbon dioxide in oxygen. 
Contraction recording
One end of the ileum segment was attached to the 
bottom of the bath and the other to an isotonic force 
transducer (TSZ-04-E, Experimetria Ltd, Budapest, 
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Hungary). The data were recorded and analyzed with 
a SPEL Advanced ISOSYS Data Acquisition System 
(Experimetria Ltd, Budapest, Hungary). The segments 
were suspended under 1-g tension and allowed to 
equilibrate for 30 min. Under these experimental con-
ditions, the segments exhibited spontaneous rhyth-
mic contractions. The investigated essential oil (CI-2) 
(dissolved in 0.5% carboxymethyl cellulose) and the 
control drugs were added directly to the organ bath 
in volumes not exceeding 1% of the bath volume [16].
Experimental procedure
The effects of essential oil on spontaneous contrac-
tions and contractions induced with ACh and KCl 
were evaluated as described previously [16]. In the 
first series of experiments, the spasmolytic effect of at-
ropine on spontaneous contractions of isolated ileum 
was investigated. Then the effect of the essential oil 
on spontaneous contractions was investigated, and the 
results are presented as % of maximal effect obtained 
with atropine. Atropine and essential oil were added 
to the water bath cumulatively and concentration re-
sponse curves were obtained.
In the second series of experiments, the effects 
of the essential oil on ACh-induced contractions was 
investigated using a single dose regimen with a con-
tact time of 30 s and time cycle of 5 min. Increasing 
concentrations of ACh were added to the organ bath 
cumulatively and a concentration-effect curve was 
generated in the absence and then in the presence 
of four different concentrations of essential oil (30, 
60, 90 and 120 μg/mL), while atropine was used as a 
control substance.
In the third experimental series, sustained, tonic 
contraction of isolated rat ileum was induced with 80 
mM KCl. Essential oil was then added to the water 
bath and a concentration-response curve was obtained 
by the cumulative addition of different concentrations 
of essential oil at 5 min intervals after the addition of 
80 mM KCl. For this experimental model, alverine 
citrate, an agent known to inhibit the sensitivity of 
contractile proteins to Ca2+, was used as a control sub-
stance. Experiments were also conducted in parallel 
with controls using the tissue from the same animal 
and adding an equivalent volume of vehicle (0.5% car-
boxymethyl cellulose) instead of essential oil.
Measurements and statistical analysis
Contractions were measured as the area under the 
curve produced by tissue contraction at 5 min inter-
vals just before the addition of the next concentration 
of the tested sample, and the results were expressed 
as the percentage of control or maximum induced 
response for each tissue. Mean and standard error 
values were calculated for each group of results (n>4 
for each set of experiments) and the significance of 
differences between the means was determined by the 
Mann-Whitney U-test using SPSS 11.5 software. A 
probability value of p<0.05 was considered signficant.
RESULTS AND DISCUSSION
Chemical analysis of the essential oil
The inflorescence of C. schoenanthus was rich in es-
sential oil, yielding 1.9-2.0% (v/w) of oil, whereas 
the content of essential oil in the stems was 0.2-0.6% 
(v/w), calculated on a dry weight basis (Table 1). The 
obtained essential oils were fragrant and yellowish. 
The results of GC and GC-MS analyses of the es-
sential oils are summarized in Table 2. More than 45 
compounds were identified in each oil, representing 
98.8-99.4% of the total oils. The oils from stems and 
inflorescence, as well as the oils originating from dif-
ferent periods of plant material collection, were simi-
lar in qualitative composition with some quantitative 
differences. All the investigated essential oils were 
characterized by a high content of oxygenated monot-
erpenes (50.8-75.5%). The dominant compound was 
piperitone (47.7-71.5%). The other abundant con-
stituents were intermedeol (6.1-17.3%), δ-2-carene 
(4.5-10.0%) and elemol (5.2-9.0%), except in the oil 
from stems collected in November 2013. 
The results of our study are in agreement with 
previous investigations into C. schoenanthus oils of 
Table1. Samples and oil yield of C. schoenanthus essential oils
Sample Collection date Plant part Oil Yield (% v/w)
CS-1
November 2013
stems 0.6
CI-1 inflorescence 2.0
CS-2
February 2015
stems 0.2
CI-2 inflorescence 1.9
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Table 2. Chemical composition of essential oils from stem and inflorescence of C. schoenanthus cultivated in Khartoum, Sudan
November 2013 February 2015
Compound KI exp StemsCS-1 (%)
Inflorescence
CI-1 (%)
Stems
CS-2 (%)
Inflorescence
CI-2 (%)
Verbenene 965 0.1 0.2 0.2 0.3
dehydro-1,8-Cineole 992 0.1 tr tr tr
δ-2-Carene 1004 6.3 10.0 4.5 9.7
α-Phellandrene 1006 tr tr tr tr
α-Terpinene 1017 tr tr tr tr
p-Cymene 1024 0.1 tr tr tr
Limonene 1028 1.5 1.9 1.1 1.8
(Z)-β-Ocimene 1036 tr tr tr tr
(E)-β-Ocimene 1049 tr tr tr tr
Fenchone 1087 0.1 tr tr tr
cis-p-Menth-2-en-1-ol 1123 0.8 0.6 tr tr
cis-p-Mentha-2,8-dien-1-ol 1137 tr tr tr tr
trans-p-Menth-2-en-ol 1140 0.6 0.4 tr tr
p-Mentha-1,5-dien-8-ol 1171 0.5 0.4 0.2 0.4
p-Methyl acetophenone 1183 tr tr tr 0.5
p-Cymen-8-ol 1184 0.2 tr tr tr
α-Terpineol 1191 0.9 0.8 0.7 0.8
cis-Piperitol 1199 tr tr tr tr
trans-Piperitol 1210 0.2 tr tr tr
cis-p-Mentha-1(7),8-dien-2-ol 1232 - - 0.3 tr
Carvotanacetone 1248 0.2 0.9 tr -
Piperitone 1253 71.5 47.7 52.9 58.7
(E)-Cinnamaldehyde 1270 0.4 - - -
α-Terpinen-7-al 1288 0.1 tr tr tr
Thymol 1294 tr tr tr tr
β-Elemene 1394 0.2 0.5 0.3 0.2
α-Barbatene 1410 tr tr tr tr
(E)-Caryophyllene 1422 1.1 2.1 0.6 1.1
Isobazzanene 1440 tr tr tr tr
β-Barbatene 1445 0.1 tr tr tr
α-Humulene 1455 0.1 tr tr tr
β-Chamigrene 1480 0.1 0.2 tr tr
α-Selinene 1501 0.2 0.3 0.6 0.2
Valencene 1502 0.3 0.4 0.7 tr
β-Dihydro-agarofuran 1506 - - tr 0.6
α-Chamigrene 1508 0.1 0.1 0.2 0.2
Cuparene 1509 0.5 0.5 0.7 0.5
β-Bazzanene 1523 0.1 tr tr tr
(7)-epi-α-Selinene 1524 0.1 tr 0.2 tr
Kessane 1532 - - tr 0.4
(E)-γ-Bisabolene 1533 0.4 0.9 0.4 0.4
Elemol 1551 2.7 9.0 5.2 5.3
Caryophyllene oxide 1585 0.8 0.3 1.3 0.7
γ-Eudesmol 1633 0.6 1.8 1.6 0.5
Hinesol 1642 tr tr 1.6 -
β-Eudesmol 1652 1.1 1.8 3.6 1.3
α-Eudesmol 1655 1.2 2.1 2.7 1.1
Intermedeol 1668 6.1 14.4 17.3 13.1
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different origin. The leaf essential oils of C. schoenan-
thus from Benin [8], Burkina Faso [17] and Togo [18] 
were also dominated by the presence of piperitone 
(42.0-69.01%), followed by δ-2-carene (8.2-16.9%) 
and elemol (4.9-6.2%). 
The essential oils of C. schoenanthus from Su-
dan analyzed in this study differentiate from previ-
ously analyzed oils in the presence of sesquiterpene 
intermedeol (6.1-17.3%), which was not detected in 
the previously analyzed oils.   
A high occurrence of piperitone also characterizes 
the essential oils of some other Cymbopogon species 
such as C. parkeri Stapf (80.8%) and C. olivieri (Boiss) 
Bor (72.8%) from Iran [3] and C. jwarancusa (Jones) 
Schultz (79.0%) from India [19]. Piperitone is an im-
portant raw material for conversion into menthol and 
thymol [19], which are well known for their medicinal 
properties and use as flavoring agents.
Spasmolytic activity
Essential oil from the inflorescence of C. schoenan-
thus exhibited strong and concentration-dependent 
spasmolytic activity. The oil (10-130 μg/mL) con-
centration-dependently inhibited spontaneous con-
tractions of isolated rat ileum. The effect was strong 
and in the concentration of 130 μg/mL comparable 
(105.23±29.56%) to the maximal relaxant effect of 
atropine obtained in a concentration of 6.4 μM in a 
previous series of experiments. The results are pre-
sented in Fig. 1.
Essential oil exhibited a concentration-dependent 
effect in the second series of experiments where the 
effect on contractions induced by ACh was investi-
gated. The spasmolytic effect of the oil was assessed 
for four concentrations (30, 60, 90 and 120 μg/mL). 
In a concentration of 30 μg/mL, the oil exhibited a 
weak effect (data not shown). At 60 μg/mL, the oil 
exhibited a strong and significant spasmolytic effect 
on contractions induced with lower concentrations 
of ACh (0.01-0.44 μg/mL). The effect on contractions 
induced with higher concentrations was weaker, in-
hibiting the maximal effect of ACh to 77.71±13.85%. 
Bulnesol 1672 tr tr 0.5 0.7
α-Bisabolol 1688 tr tr tr tr
Hexadecanoic acid 1962 - - 0.4 -
Methyl linoleate 2098 - 0.2 - -
Oleic acid 2144 - 0.7 - -
Identified 99.4 98.2 97.8 98.5
Monoterpene hydrocarbons 8.1 12.1 5.8 11.8
Oxygenated monoterpenes 75.5 50.8 54.1 59.9
Sesquiterpene hydrocarbons 3.3 5.0 3.7 3.2
Oxygenated sesquiterpenes 12.5 29.4 33.8 23.1
Others tr 0.9 0.4 0.5
a KI exp − Relative retention indices calculated against n-alkane on HP-5MS column.
b % − Relative area percentage.
c tr − trace (<0.05%).
Table 2. continued
Fig. 1. Effect of C. schoenanthus inflorescence essential oil on 
spontaneous contractions of the isolated rat ileum compared with 
atropine. Activity is presented as the percentage of maximal spas-
molytic effect achieved with atropine at a concentration of 6.4 
μM (4.44 μg/mL). The concentrations presented on the x-axis are 
the final cumulative concentrations; and each point represents 
means±SEM of five or more experiments. Stars show statistically 
significant differences in comparison with the control, the vehicle 
(Na-CMC)-treated group (**p<0.01).
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In the concentration of 90 μg/mL, the oil exhibited 
similar activity at lower concentrations of ACh (0.01-
0.44 μg/mL), but the effect on contractions induced 
with higher concentrations was stronger and signifi-
cant, with an inhibition of the maximal effect of ACh 
to 62.76±21.00%. At 120 μg/mL, the oil exhibited the 
strongest relaxant activity and completely abolished 
the contractile effect of ACh (data not shown). The re-
sults are shown in Fig. 2. Atropine, used as a reference 
drug in this model, exhibited stronger activity and in 
a concentration of 0.14 μM completely inhibited the 
spasmogenic effect of ACh. 
The oil demonstrated the strongest activity against 
tonic contractions induced with KCl (80 mM). At 30 
μg/mL, the oil inhibited the contractile effect of KCl 
to 19.67±20.26%. The results are presented in Fig. 3. 
Piperitone, the main metabolite of the investigated 
essential oil (58.7%), was previously shown to exhibit 
spasmolytic activity. Tested in a range of 1-100 μg/mL, 
piperitone concentration-dependently inhibited con-
tractions of isolated rat uterus contracted with KCl (60 
mM) with a calculated EC50=10.73±1.27 μg/mL [20]. 
It was previously shown that limonene, a minor com-
ponent of this oil, exhibits spasmolytic activity as well 
[21]. Relaxant activity was previously demonstrated 
for β-eudesmol, another minor metabolite of C. sch-
oenanthus essential oil (1.3%). This sesquiterpene in-
hibited histamine- and barium chloride-induced con-
tractions of guinea-pig ileum [22]. Additionally, the 
essential oil of Perovskia abrotanoides Kar. exhibited 
a relaxant effect on spontaneous and KCl (80 mM)-
induced contractions of isolated rabbit jejunum. The 
main metabolite of this oil was δ-3-carene [23]. There-
fore, δ-2-carene present in C. schoenanthus essential 
oil (9.7%) might contribute to the demonstrated ac-
tivity of the oil. It could be postulated that the strong 
spasmolytic activity of C. schoenanthus inflorescence 
essential oil demonstrated in our experiments could 
be partly due to the presence of piperitone.
CONCLUSION
A high essential oil content and stable composition 
makes C. schoenanthus from Sudan a valuable source 
of the commercially important monoterpene, piperi-
tone. Significant spasmolytic activity of inflorescence 
essential oil was observed, emphasizing its beneficial 
properties, especially for gastrointestinal complaints. 
Our data represent a good basis for further investiga-
tions of this essential oil for its medicinal purposes, as 
well as for application in the food industry.
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Fig. 2. Concentration-response curves of ACh in the absence 
(rhombus) and presence of 60 μg/mL (square) and 90 μg/mL (tri-
angle) of C. schoenanthus inflorescence essential oil in isolated 
rat ileum. The values presented on the y-axis represent responses 
expressed as percentages of the maximum response to ACh. Each 
point represents means±SEM of seven or more experiments. Stars 
show statistically significant differences in comparison with the 
control, the vehicle (Na-CMC)-treated group (*p<0.05, **p<0.01).
Fig. 3. Concentration-related inhibitory effects of C. schoenanthus 
inflorescence essential oil on contractions induced with KCl (80 
mM) in isolated rat ileum. The spasmolytic effect of the essential 
oil is represented by the decrease (values on the y-axis) of KCl 
contractile effect (100%). Each point represents means±SEM of 
four or more experiments. Stars show statistically significant dif-
ferences in comparison with control data – vehicle (Na-CMC) 
treated group (*p<0.05).
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